Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-10-17

AUTHORS

Susan Gillespie, Jodie Borrow, Xu Dong Zhang, Peter Hersey

ABSTRACT

The wide variation in sensitivity of cancer cells to TRAIL- or histone deacetylase (HDAC) inhibitor — induced apoptosis precludes successful treatment of cancer with these agents. We report here that TRAIL and SBHA synergistically induce apoptosis of melanoma cells as revealed by quantitative analysis using the normalized isobologram method. This is supported by enhanced activation of caspase-3 and cleavage of its substrates, PARP and ICAD. Co-treatment with SBHA and TRAIL did not enhance formation of the death-inducing signaling complex (DISC) and processing of caspase-8 and Bid, but potentiated activation of Bax and release of Cytochrome C and Smac/DIABLO from mitochondria into the cytosol. SBHA down-regulated Bcl-XL, Mcl-1 and XIAP, but up-regulated Bax, Bak, and the BH3-only protein BimEL. Up-regulation of the latter by SBHA was attenuated by the presence of TRAIL, which was inhibitable by the pan-caspase inhibitor z-VAD-fmk. Inhibition of Bim by siRNA attenuated conformational changes of Bax, mitochondrial apoptotic events, and activation of caspase-3, leading to marked inhibition of the synergy between SBHA and TRAIL. Thus, Bim plays an essential role in synergistic induction of apoptosis by SBHA and TRAIL in melanoma. More... »

PAGES

2251-2265

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10495-006-0283-6

DOI

http://dx.doi.org/10.1007/s10495-006-0283-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032980663

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17051334


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis Regulatory Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "BH3 Interacting Domain Death Agonist Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bcl-2-Like Protein 11", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspase 8", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Down-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Histone Deacetylase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Histone Deacetylases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxamic Acids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitochondria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myeloid Cell Leukemia Sequence 1 Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcl-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Small Interfering", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "TNF-Related Apoptosis-Inducing Ligand", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Up-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "X-Linked Inhibitor of Apoptosis Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "bcl-2 Homologous Antagonist-Killer Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "bcl-2-Associated X Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "bcl-X Protein", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, Newcastle Misericordiae Hospital, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, Newcastle Misericordiae Hospital, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gillespie", 
        "givenName": "Susan", 
        "id": "sg:person.01311773466.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311773466.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, Newcastle Misericordiae Hospital, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, Newcastle Misericordiae Hospital, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Borrow", 
        "givenName": "Jodie", 
        "id": "sg:person.01140572250.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140572250.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, Newcastle Misericordiae Hospital, NSW, Australia", 
            "Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Xu Dong", 
        "id": "sg:person.01210116316.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, Newcastle Misericordiae Hospital, NSW, Australia", 
            "Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hersey", 
        "givenName": "Peter", 
        "id": "sg:person.01073667716.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1207830", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049638392", 
          "https://doi.org/10.1038/sj.onc.1207830"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncb1026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012014764", 
          "https://doi.org/10.1038/ncb1026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/20959", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031691936", 
          "https://doi.org/10.1038/20959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4401535", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015856802", 
          "https://doi.org/10.1038/sj.cdd.4401535"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35101078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021222128", 
          "https://doi.org/10.1038/35101078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4401507", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020681987", 
          "https://doi.org/10.1038/sj.cdd.4401507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1207970", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048306287", 
          "https://doi.org/10.1038/sj.onc.1207970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/38664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026663914", 
          "https://doi.org/10.1038/38664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1208191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030634267", 
          "https://doi.org/10.1038/sj.onc.1208191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/5517", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010598958", 
          "https://doi.org/10.1038/5517"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-10-17", 
    "datePublishedReg": "2006-10-17", 
    "description": "The wide variation in sensitivity of cancer cells to TRAIL- or histone deacetylase (HDAC) inhibitor \u2014 induced apoptosis precludes successful treatment of cancer with these agents. We report here that TRAIL and SBHA synergistically induce apoptosis of melanoma cells as revealed by quantitative analysis using the normalized isobologram method. This is supported by enhanced activation of caspase-3 and cleavage of its substrates, PARP and ICAD. Co-treatment with SBHA and TRAIL did not enhance formation of the death-inducing signaling complex (DISC) and processing of caspase-8 and Bid, but potentiated activation of Bax and release of Cytochrome C and Smac/DIABLO from mitochondria into the cytosol. SBHA down-regulated Bcl-XL, Mcl-1 and XIAP, but up-regulated Bax, Bak, and the BH3-only protein BimEL. Up-regulation of the latter by SBHA was attenuated by the presence of TRAIL, which was inhibitable by the pan-caspase inhibitor z-VAD-fmk. Inhibition of Bim by siRNA attenuated conformational changes of Bax, mitochondrial apoptotic events, and activation of caspase-3, leading to marked inhibition of the synergy between SBHA and TRAIL. Thus, Bim plays an essential role in synergistic induction of apoptosis by SBHA and TRAIL in melanoma.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10495-006-0283-6", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1117236", 
        "issn": [
          "1360-8185", 
          "1573-675X"
        ], 
        "name": "Apoptosis", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "histone deacetylase inhibitor-induced apoptosis", 
      "pan-caspase inhibitor z-VAD", 
      "mitochondrial apoptotic events", 
      "inhibition of Bim", 
      "Smac/DIABLO", 
      "synergistic induction", 
      "activation of Bax", 
      "inhibitor-induced apoptosis", 
      "caspase-3", 
      "protein BimEL", 
      "melanoma cells", 
      "Z-VAD", 
      "apoptotic events", 
      "caspase-8", 
      "Bcl-xL", 
      "Mcl-1", 
      "conformational changes", 
      "cytochrome c", 
      "essential role", 
      "presence of TRAIL", 
      "apoptosis", 
      "cancer cells", 
      "SBHA", 
      "Bax", 
      "enhanced activation", 
      "cells", 
      "activation", 
      "crucial role", 
      "BimEL", 
      "induction", 
      "fmk", 
      "XIAP", 
      "Bak", 
      "BH3", 
      "DIABLO", 
      "mitochondria", 
      "cytosol", 
      "BIM", 
      "inhibition", 
      "PARP", 
      "marked inhibition", 
      "siRNA", 
      "ICAD", 
      "role", 
      "trails", 
      "cleavage", 
      "complexes", 
      "substrate", 
      "wide variation", 
      "variation", 
      "formation", 
      "release", 
      "quantitative analysis", 
      "cancer", 
      "events", 
      "presence", 
      "changes", 
      "melanoma", 
      "isobologram method", 
      "analysis", 
      "synergy", 
      "agents", 
      "bid", 
      "sensitivity", 
      "treatment", 
      "processing", 
      "method", 
      "successful treatment"
    ], 
    "name": "Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells", 
    "pagination": "2251-2265", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032980663"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10495-006-0283-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17051334"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10495-006-0283-6", 
      "https://app.dimensions.ai/details/publication/pub.1032980663"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_427.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10495-006-0283-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10495-006-0283-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10495-006-0283-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10495-006-0283-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10495-006-0283-6'


 

This table displays all metadata directly associated to this object as RDF triples.

300 TRIPLES      21 PREDICATES      130 URIs      110 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10495-006-0283-6 schema:about N0924592d6af8491d80dbc4112cb405d0
2 N0bd3fed7f2364346b4bd630124e81faf
3 N0d4c9004d25c49aeb78376d8dd9fddc0
4 N15caaacf54d04d158b8dc1f50270251d
5 N194db427a384418ab2b1fb1d5f0b922d
6 N220933c8b1bc40fd88ab67155410e365
7 N2a10671cd1e74ce1a57e286db7b2e524
8 N33aa3d60fe774d9f99219014b8098993
9 N37a704ad712b4de5aa6acde5989545f2
10 N3982f43380a64900aa1bc035b9ee3254
11 N492c7192329d4e4fa966c4b4c94194df
12 N5516c7bd4f6d431dbfc2c8107d278292
13 N709fe378437a44f9a0cef2e05899d823
14 N79be1210dacd44aabf5805783033392a
15 N8a99dac77982463e85a4d4b225ce8196
16 N970432d424bf4e0f86aac6fc9d064bd8
17 N97148651558241d98ee281fb5590043a
18 N97bcc8b4ae2f40f5a491e11ace02bcec
19 N98489ce06bfa4bf5b8214fd253e26155
20 N99353c71e7ba4f6994ebecc93147a09e
21 N9986b5f9a6b2496bbfcf47c487ba44ed
22 Naa5e9fafe8304f5eb70ee93939874be1
23 Nb7bf19ace1df42a7b5063e892c62f993
24 Ncee400d7a75f422d97ff32b509aac971
25 Nf10a053b8fe540c0a24dc3d11d9b530e
26 anzsrc-for:06
27 anzsrc-for:0601
28 anzsrc-for:11
29 anzsrc-for:1112
30 schema:author N12fca9555a9c456fa3ad91a8b13f7c54
31 schema:citation sg:pub.10.1038/20959
32 sg:pub.10.1038/35101078
33 sg:pub.10.1038/38664
34 sg:pub.10.1038/5517
35 sg:pub.10.1038/ncb1026
36 sg:pub.10.1038/sj.cdd.4401507
37 sg:pub.10.1038/sj.cdd.4401535
38 sg:pub.10.1038/sj.onc.1207830
39 sg:pub.10.1038/sj.onc.1207970
40 sg:pub.10.1038/sj.onc.1208191
41 schema:datePublished 2006-10-17
42 schema:datePublishedReg 2006-10-17
43 schema:description The wide variation in sensitivity of cancer cells to TRAIL- or histone deacetylase (HDAC) inhibitor — induced apoptosis precludes successful treatment of cancer with these agents. We report here that TRAIL and SBHA synergistically induce apoptosis of melanoma cells as revealed by quantitative analysis using the normalized isobologram method. This is supported by enhanced activation of caspase-3 and cleavage of its substrates, PARP and ICAD. Co-treatment with SBHA and TRAIL did not enhance formation of the death-inducing signaling complex (DISC) and processing of caspase-8 and Bid, but potentiated activation of Bax and release of Cytochrome C and Smac/DIABLO from mitochondria into the cytosol. SBHA down-regulated Bcl-XL, Mcl-1 and XIAP, but up-regulated Bax, Bak, and the BH3-only protein BimEL. Up-regulation of the latter by SBHA was attenuated by the presence of TRAIL, which was inhibitable by the pan-caspase inhibitor z-VAD-fmk. Inhibition of Bim by siRNA attenuated conformational changes of Bax, mitochondrial apoptotic events, and activation of caspase-3, leading to marked inhibition of the synergy between SBHA and TRAIL. Thus, Bim plays an essential role in synergistic induction of apoptosis by SBHA and TRAIL in melanoma.
44 schema:genre article
45 schema:isAccessibleForFree false
46 schema:isPartOf Naef928c196de42b2b2e8847ec814cca5
47 Nd5608d4ed9724139bca6eaf4be6a962e
48 sg:journal.1117236
49 schema:keywords BH3
50 BIM
51 Bak
52 Bax
53 Bcl-xL
54 BimEL
55 DIABLO
56 ICAD
57 Mcl-1
58 PARP
59 SBHA
60 Smac/DIABLO
61 XIAP
62 Z-VAD
63 activation
64 activation of Bax
65 agents
66 analysis
67 apoptosis
68 apoptotic events
69 bid
70 cancer
71 cancer cells
72 caspase-3
73 caspase-8
74 cells
75 changes
76 cleavage
77 complexes
78 conformational changes
79 crucial role
80 cytochrome c
81 cytosol
82 enhanced activation
83 essential role
84 events
85 fmk
86 formation
87 histone deacetylase inhibitor-induced apoptosis
88 induction
89 inhibition
90 inhibition of Bim
91 inhibitor-induced apoptosis
92 isobologram method
93 marked inhibition
94 melanoma
95 melanoma cells
96 method
97 mitochondria
98 mitochondrial apoptotic events
99 pan-caspase inhibitor z-VAD
100 presence
101 presence of TRAIL
102 processing
103 protein BimEL
104 quantitative analysis
105 release
106 role
107 sensitivity
108 siRNA
109 substrate
110 successful treatment
111 synergistic induction
112 synergy
113 trails
114 treatment
115 variation
116 wide variation
117 schema:name Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells
118 schema:pagination 2251-2265
119 schema:productId N062fef8fc4864c339949ba09c5a2ede2
120 N864877e181684be0b10b76a11ec59a7b
121 N9f6d8665d7d740e5a2c1343a853efd80
122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032980663
123 https://doi.org/10.1007/s10495-006-0283-6
124 schema:sdDatePublished 2022-10-01T06:33
125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
126 schema:sdPublisher Nf17dd441858e4c79a9aeddcc2ddf1ff1
127 schema:url https://doi.org/10.1007/s10495-006-0283-6
128 sgo:license sg:explorer/license/
129 sgo:sdDataset articles
130 rdf:type schema:ScholarlyArticle
131 N062fef8fc4864c339949ba09c5a2ede2 schema:name dimensions_id
132 schema:value pub.1032980663
133 rdf:type schema:PropertyValue
134 N0924592d6af8491d80dbc4112cb405d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Hydroxamic Acids
136 rdf:type schema:DefinedTerm
137 N0bd3fed7f2364346b4bd630124e81faf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name X-Linked Inhibitor of Apoptosis Protein
139 rdf:type schema:DefinedTerm
140 N0d4c9004d25c49aeb78376d8dd9fddc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Bcl-2-Like Protein 11
142 rdf:type schema:DefinedTerm
143 N12fca9555a9c456fa3ad91a8b13f7c54 rdf:first sg:person.01311773466.89
144 rdf:rest N71e786979569426397bab9866f0e2e1f
145 N15caaacf54d04d158b8dc1f50270251d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Enzyme Inhibitors
147 rdf:type schema:DefinedTerm
148 N194db427a384418ab2b1fb1d5f0b922d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name TNF-Related Apoptosis-Inducing Ligand
150 rdf:type schema:DefinedTerm
151 N220933c8b1bc40fd88ab67155410e365 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Up-Regulation
153 rdf:type schema:DefinedTerm
154 N2402e5b426554a94821a154a704047e3 rdf:first sg:person.01073667716.42
155 rdf:rest rdf:nil
156 N2a10671cd1e74ce1a57e286db7b2e524 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Myeloid Cell Leukemia Sequence 1 Protein
158 rdf:type schema:DefinedTerm
159 N33aa3d60fe774d9f99219014b8098993 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name bcl-X Protein
161 rdf:type schema:DefinedTerm
162 N37a704ad712b4de5aa6acde5989545f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Proto-Oncogene Proteins
164 rdf:type schema:DefinedTerm
165 N3982f43380a64900aa1bc035b9ee3254 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Apoptosis
167 rdf:type schema:DefinedTerm
168 N492c7192329d4e4fa966c4b4c94194df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Down-Regulation
170 rdf:type schema:DefinedTerm
171 N5516c7bd4f6d431dbfc2c8107d278292 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Histone Deacetylase Inhibitors
173 rdf:type schema:DefinedTerm
174 N709fe378437a44f9a0cef2e05899d823 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Humans
176 rdf:type schema:DefinedTerm
177 N71e786979569426397bab9866f0e2e1f rdf:first sg:person.01140572250.01
178 rdf:rest Naffff1a669c74b97b1a66008debff1a9
179 N79be1210dacd44aabf5805783033392a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Histone Deacetylases
181 rdf:type schema:DefinedTerm
182 N864877e181684be0b10b76a11ec59a7b schema:name doi
183 schema:value 10.1007/s10495-006-0283-6
184 rdf:type schema:PropertyValue
185 N8a99dac77982463e85a4d4b225ce8196 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Caspase 8
187 rdf:type schema:DefinedTerm
188 N970432d424bf4e0f86aac6fc9d064bd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Neoplasm Proteins
190 rdf:type schema:DefinedTerm
191 N97148651558241d98ee281fb5590043a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Mitochondria
193 rdf:type schema:DefinedTerm
194 N97bcc8b4ae2f40f5a491e11ace02bcec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Proto-Oncogene Proteins c-bcl-2
196 rdf:type schema:DefinedTerm
197 N98489ce06bfa4bf5b8214fd253e26155 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name RNA, Small Interfering
199 rdf:type schema:DefinedTerm
200 N99353c71e7ba4f6994ebecc93147a09e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name bcl-2-Associated X Protein
202 rdf:type schema:DefinedTerm
203 N9986b5f9a6b2496bbfcf47c487ba44ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Membrane Proteins
205 rdf:type schema:DefinedTerm
206 N9f6d8665d7d740e5a2c1343a853efd80 schema:name pubmed_id
207 schema:value 17051334
208 rdf:type schema:PropertyValue
209 Naa5e9fafe8304f5eb70ee93939874be1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name bcl-2 Homologous Antagonist-Killer Protein
211 rdf:type schema:DefinedTerm
212 Naef928c196de42b2b2e8847ec814cca5 schema:issueNumber 12
213 rdf:type schema:PublicationIssue
214 Naffff1a669c74b97b1a66008debff1a9 rdf:first sg:person.01210116316.18
215 rdf:rest N2402e5b426554a94821a154a704047e3
216 Nb7bf19ace1df42a7b5063e892c62f993 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Melanoma
218 rdf:type schema:DefinedTerm
219 Ncee400d7a75f422d97ff32b509aac971 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name BH3 Interacting Domain Death Agonist Protein
221 rdf:type schema:DefinedTerm
222 Nd5608d4ed9724139bca6eaf4be6a962e schema:volumeNumber 11
223 rdf:type schema:PublicationVolume
224 Nf10a053b8fe540c0a24dc3d11d9b530e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
225 schema:name Apoptosis Regulatory Proteins
226 rdf:type schema:DefinedTerm
227 Nf17dd441858e4c79a9aeddcc2ddf1ff1 schema:name Springer Nature - SN SciGraph project
228 rdf:type schema:Organization
229 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
230 schema:name Biological Sciences
231 rdf:type schema:DefinedTerm
232 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
233 schema:name Biochemistry and Cell Biology
234 rdf:type schema:DefinedTerm
235 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
236 schema:name Medical and Health Sciences
237 rdf:type schema:DefinedTerm
238 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
239 schema:name Oncology and Carcinogenesis
240 rdf:type schema:DefinedTerm
241 sg:journal.1117236 schema:issn 1360-8185
242 1573-675X
243 schema:name Apoptosis
244 schema:publisher Springer Nature
245 rdf:type schema:Periodical
246 sg:person.01073667716.42 schema:affiliation grid-institutes:None
247 schema:familyName Hersey
248 schema:givenName Peter
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42
250 rdf:type schema:Person
251 sg:person.01140572250.01 schema:affiliation grid-institutes:None
252 schema:familyName Borrow
253 schema:givenName Jodie
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140572250.01
255 rdf:type schema:Person
256 sg:person.01210116316.18 schema:affiliation grid-institutes:None
257 schema:familyName Zhang
258 schema:givenName Xu Dong
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18
260 rdf:type schema:Person
261 sg:person.01311773466.89 schema:affiliation grid-institutes:None
262 schema:familyName Gillespie
263 schema:givenName Susan
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311773466.89
265 rdf:type schema:Person
266 sg:pub.10.1038/20959 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031691936
267 https://doi.org/10.1038/20959
268 rdf:type schema:CreativeWork
269 sg:pub.10.1038/35101078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021222128
270 https://doi.org/10.1038/35101078
271 rdf:type schema:CreativeWork
272 sg:pub.10.1038/38664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026663914
273 https://doi.org/10.1038/38664
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/5517 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010598958
276 https://doi.org/10.1038/5517
277 rdf:type schema:CreativeWork
278 sg:pub.10.1038/ncb1026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012014764
279 https://doi.org/10.1038/ncb1026
280 rdf:type schema:CreativeWork
281 sg:pub.10.1038/sj.cdd.4401507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020681987
282 https://doi.org/10.1038/sj.cdd.4401507
283 rdf:type schema:CreativeWork
284 sg:pub.10.1038/sj.cdd.4401535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015856802
285 https://doi.org/10.1038/sj.cdd.4401535
286 rdf:type schema:CreativeWork
287 sg:pub.10.1038/sj.onc.1207830 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049638392
288 https://doi.org/10.1038/sj.onc.1207830
289 rdf:type schema:CreativeWork
290 sg:pub.10.1038/sj.onc.1207970 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048306287
291 https://doi.org/10.1038/sj.onc.1207970
292 rdf:type schema:CreativeWork
293 sg:pub.10.1038/sj.onc.1208191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030634267
294 https://doi.org/10.1038/sj.onc.1208191
295 rdf:type schema:CreativeWork
296 grid-institutes:None schema:alternateName Immunology and Oncology Unit, Room 443, Newcastle Misericordiae Hospital, NSW, Australia
297 Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia
298 schema:name Immunology and Oncology Unit, Room 443, Newcastle Misericordiae Hospital, NSW, Australia
299 Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia
300 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...